SOURCE: Signal Watch

Signal Watch

August 25, 2011 08:36 ET

Analytical Reports on HEALTHSOUTH Corp. and DaVita Inc. - Specialized Health Services to Be Helped by Better Reimbursement Rates

NEW YORK, NY--(Marketwire - Aug 25, 2011) - www.SignalWatcher.com provides members with proprietary analysis of over 10,000 stocks which is updated every day. Today, members can receive their complimentary stock analysis on HEALTHSOUTH Corp. (NYSE: HLS) and DaVita Inc. (NYSE: DVA). Sign up now on www.SignalWatcher.com to get your free reports on these stocks.

Specialized health care providers should benefit from the U.S. government's announcement that the rate of Medicare reimbursement payments will increase in 2012.

www.SignalWatcher.com brings investors free classic analysis on HEALTHSOUTH Corp., DaVita Inc. and other companies within the Specialized Health Services industry. This type of analysis is only a fragment of the information members have available to them. To learn more we encourage investors to sign up at http://signalwatcher.com/EmailSignup.php.

The Centers for Medicare and Medicaid Services increased payment rates by 1% and expects payments to acute-care hospitals to surge by $1.13 billion in 2012. The news of higher reimbursement rates is positive, but concerns of further budget cuts still remain for the health sector as a whole.

Both HEALTHSOUTH Corp. and DaVita Inc. should benefit from the increased reimbursement rates. Roughly 87% of DaVita's patients are funded by Medicaid or Medicare. www.SignalWatcher.com gives traders a unique insight about HEALTHSOUTH Corp. and DaVita Inc. by registering now at

http://signalwatcher.com/HLS/August252011.php or

http://signalwatcher.com/DVA/August252011.php.

Despite the positive change, healthcare stocks saw a lot of selling action in the beginning of the month, as investors feared the effects that the Budget Control Act would have. The ramifications for the health industry do not appear to be as far reaching as once thought and investor confidence will likely return as the actual effects of the bill are realized.

About Signal Watch

Signal Watch's #1 goal is to help customers successfully engage the markets. For over 20 years, we have been developing the most powerful trading software available anywhere. But the software is only part of our mission. We also provide education and customer support designed to enable our customers to take control of their financial future.

Read our disclaimer by clicking on the following link http://www.signalwatch.com/disclaimers.aspx

Contact Information